Abbott Revamps Chronic Pain Device App

April 27, 2022

Abbot’s Neurosphere myPath app helps patients with chronic pain self-report the pain relief they experience with the company’s spinal cord stimulation and dorsal root ganglion devices. Initially launched in early 2021, the app is used by patients testing an external neurostimulator during a trial period to help determine whether implantation will provide sufficient pain relief.

According to Phil Taylor, “The new version of the app is suitable for use with both Apple and Android devices and can provide a shared view of patient-reported outcomes (PRO) like pain relief, ability to perform daily activities and sleep quality, throughout each stage of the treatment, said Abbott.”

To read more, click here.

(Source: PharmaPhorum, April 26th, 2022)

Share This Story!